Two leading medical stocks that appear reasonable at current levels are AbbVie ( ABBV 0.78%) and Merck ( MRK +0.31%). The former has actually beaten the market in 2025, while the latter is in the red ...
D-Wave Quantum (NYSE: QBTS) calls itself "a leader in the development and delivery of quantum computing systems, software, ...
WASHINGTON (AP) — This holiday season isn’t quite so merry for American shoppers as large shares are dipping into savings, ...
Investor's Business Daily on MSN
Strategy, bitcoin slide ahead of today's defining test
Saylor and Le note in their letter to MSCI that Strategy "has at times traded at multiples higher" than the value of the ...
IBM ecosystem executive Kareem Yusuf talks about Instana, Watsonx, and partner programs as the channel enters 2026.
Dads in this generation stand out for their zeal for retail, according to our study of 1,000 U.S. based millennial parents.
Whether Netflix or Paramount buys Warner Bros., entertainment oligopolies are back -- bigger and more anticompetitive ...
Sumitomo Corporation stock is a "Buy" amid growth-driven moves, including the SCSK acquisition. Learn more about SSUMY stock ...
These five high-yield stock picks from the J.P. Morgan December Analyst Focus List make sense now for growth and income ...
A new AP-NORC poll finds this holiday season isn’t quite so merry for American shoppers as large shares of them are dipping ...
Natural Resource Partners advances with strong cash flow, fast deleveraging and diversified assets supporting value. See why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback